• Angiotensin III Workflows for RAAS Research

  2026-09-28

  Build controlled RAAS, receptor-signaling, and exploratory spike-binding assays with Angiotensin III (human, mouse). This workflow emphasizes fresh-solution handling, concentration design, orthogonal readouts, and clear boundaries between established endocrine biology and emerging viral-receptor observations.

• CTOP for μ-Opioid Receptor Research

  2026-09-28

  Use CTOP to test whether μ-opioid receptor activation contributes to opioid-driven signaling and mechanical hypersensitivity. A practical workflow links receptor-level controls to the brain–spinal circuit findings of a 2024 mouse study, while keeping CTOP’s role distinct from cell-type-specific methods.

• TG003 Workflow for Clk-Linked Splicing Research

  2026-09-27

  TG003 offers a reversible way to probe Clk-dependent phosphorylation and alternative splice-site choice, with a workflow designed to separate splicing effects from broader kinase and cell-state changes. The article also explains how to use the ovarian-cancer CLK2 findings to shape testable experiments—without implying that TG003 was validated in that study.

• Genistein in Mechanostress Autophagy Research

  2026-09-26

  Use Genistein to test whether growth-factor kinase signaling contributes to stress responses—while keeping cytoskeletal force sensing and drug effects experimentally distinct. This workflow pairs dose-aware cell assays with mechanical-stress controls to help interpret autophagy, proliferation, and cell-death readouts.

• E. coli Uracil-DNA Glycosylase (UDG) Workflow

  2026-09-25

  E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA and can be used to reduce carryover from uracil-containing PCR products. It is not active on RNA or oligonucleotides shorter than six bases, and is intended for research workflows rather than diagnostic or medical use.

• Protease Inhibitor Cocktail for CRC Signaling Studies

  2026-09-25

  Protect signaling proteins during colorectal cancer lysate preparation with an EDTA-free, DMSO-based inhibitor format that can suit workflows requiring divalent cations. This practical guide connects careful sample handling to the PI3K/AKT/mTOR findings in a recent tetrahydrocurcumin-derivative study—without implying the researchers used this product.

• Milk EV Uptake in Porcine Intestinal Stem Cell Models

  2026-09-24

  This study compares three porcine intestinal stem cell–based models to show how epithelial polarity and intestinal region shape uptake and responses to milk-derived extracellular vesicles. Its model-validation and inhibition experiments offer a more physiologically relevant framework for investigating vesicle access, internalization, and epithelial effects than cell-line assays alone.

• DMG-PEG2000-NH2: Linker Facts & Workflow

  2026-09-24

  DMG-PEG2000-NH2 is an NH2-PEG derivative with a primary amine intended for coupling to compatible carboxyl-containing molecules. The product information reports its molecular weight, solvent-specific solubility, purity, and storage condition; these specifications describe the material, not proven delivery performance.

• Endothelial SGK1 Mediates Salt-Related Vascular Stiffening

  2026-09-23

  Zhang et al. combine genetic mouse models with human aortic endothelial-cell experiments to identify endothelial SGK1 as a mediator of salt- and mineralocorticoid-associated vascular stiffening. Their findings connect SGK1 activity with endothelial actin polymerization and support further mechanistic work on salt-sensitive vascular dysfunction, while leaving clinical efficacy and the precise downstream pathway unresolved.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-09-23

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to AXL, with shorter and N-terminally truncated peptides showing particularly strong effects. The work links renin–angiotensin biology to viral receptor engagement while emphasizing that the evidence currently comes from antibody-based binding assays rather than infection or clinical studies.

• Cabazitaxel (XRP6258) Workflow Guide

  2026-09-22

  Cabazitaxel (XRP6258, SKU B2157) supports cell-based studies of microtubule dynamics disruption, antiproliferative responses, and taxane-resistant cancer models. It is water-insoluble, so use validated DMSO- or ethanol-based preparation and prompt solution use rather than direct aqueous preparation or long-term solution storage.

• HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L)

  2026-09-22

  Learn how HyperFluor™ 488 Rabbit Anti-Goat IgG (H+L) Antibody, SKU K1214, can strengthen orthogonal fluorescence readouts in viability, proliferation, cytotoxicity, and hypoxia studies. This scenario-based guide covers compatibility, protocol control, interpretation, and practical vendor-selection criteria.

• Apigenin Workflows for HDAC and Neuroprotection

  2026-09-21

  Apigenin supports mechanism-led workflows spanning malignant mesothelioma cell growth inhibition, HDAC-linked apoptosis, and neuroinflammation models. This guide connects concentration and handling decisions with ROS, DNA damage, mitochondrial, and pathway-level readouts for more interpretable experiments.

• EPZ5676 and the Next Era of DOT1L Translation

  2026-09-21

  EPZ5676 illustrates how precise DOT1L engagement can connect H3K79 methylation inhibition with MLL-rearranged leukemia treatment, while emerging multiple myeloma data expand the translational rationale toward innate immune signaling and biomarker-led combination strategies.

• Dextromethorphan Hydrobromide: Assay Logic

  2026-09-20

  Dextromethorphan hydrobromide is a versatile NMDA receptor antagonist for linking ion-channel pharmacology to neuroprotection research. This article develops an evidence-to-assay framework informed by, but mechanistically distinct from, a seminal PDK4 inhibitor study.

670 records 1/45 page Next 12345 下5页 Last page